Anxo Pharmaceutical Co Ltd
TPEX:6677
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Anxo Pharmaceutical Co Ltd
TPEX:6677
|
TW |
|
Plandai Biotechnology Inc
OTC:PLPL
|
US |
|
S
|
Sukgyung AT Co Ltd
KOSDAQ:357550
|
KR |
|
Fansunite Entertainment Inc
OTC:FUNFF
|
CA |
|
S
|
Savoreat Ltd
TASE:SVRT
|
IL |
|
SNC-Lavalin Group Inc
TSX:ATRL
|
CA |
|
Molecular Partners AG
SIX:MOLN
|
CH |
|
First National Bank Alaska
OTC:FBAK
|
US |
|
M
|
Mildef Crete Inc
TPEX:3213
|
TW |
|
D
|
Dawon Nexview Co Ltd
KOSDAQ:323350
|
KR |
|
D
|
Danone SA
SWB:BSND
|
FR |
|
DTS Corp
F:DA9
|
JP |
|
I
|
Intertech SA
ATHEX:INTET
|
GR |
|
V
|
Vinacomin HaTu Coal JSC
VN:THT
|
VN |
|
Transmedics Group Inc
NASDAQ:TMDX
|
US |
|
P
|
Petroleo Brasileiro SA Petrobras
SWB:PJXC
|
BR |
|
C
|
CK Hutchison Holdings Ltd
SWB:2CK
|
HK |
|
Silverline Endustri ve Ticaret AS
IST:SILVR.E
|
TR |
|
S
|
SUIC Worldwide Holdings Ltd
OTC:SUIC
|
US |
|
R
|
Realord Group Holdings Ltd
SWB:CUV
|
HK |
|
Izertis SA
MAD:IZER
|
ES |
|
Aegis Brands Inc
OTC:SCUPF
|
CA |
|
G
|
Global Quest Ltd
OTC:GLBB
|
KR |
Dividends
Dividend Yield
Anxo Pharmaceutical Co Ltd
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Anxo Pharmaceutical Co Ltd
Payout Ratio
Anxo Pharmaceutical Co Ltd
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for Anxo Pharmaceutical Co Ltd is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
Anxo Pharmaceutical Co Ltd
| Average Annual Return | 4.75% |
| Standard Deviation of Annual Returns | 45.37% |
| Max Drawdown | -78% |
| Market Capitalization | 1.1B TWD |
| Shares Outstanding | 56 040 000 |
| Percentage of Shares Shorted |
N/A
|
Return Decomposition
Main factors of price return
Stock Splits
Anxo Pharmaceutical Co Ltd's latest stock split occurred on Nov 1, 2021
The company executed a 1050-for-1000 stock split, meaning that for every 1000 shares held, investors received 1050 new shares.
Before the split, Anxo Pharmaceutical Co Ltd traded at 23.34 per share. Afterward, the share price was about 22.8847.
The adjusted shares began trading on Nov 1, 2021. This was stock split number 2 in Anxo Pharmaceutical Co Ltd's history, following the previous one in Jul 15, 2019.